Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 269: C1250-C1264, 1995;
0363-6143/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrand, N.
Right arrow Articles by Rosselin, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrand, N.
Right arrow Articles by Rosselin, G.

AJP - Cell Physiology, Vol 269, Issue 5 C1250-C1264, Copyright © 1995 by American Physiological Society

ARTICLES

Dynamics of pancreatic cell growth and differentiation during diabetes reversion in STZ-treated newborn rats

N. Ferrand, A. Astesano, H. H. Phan, C. Lelong and G. Rosselin
Unite de Recherches sur les Peptides Neurodigestifs et le Diabete, Institut National de la Sante et de la Recherche Medicale U.55, Centre de Recherches Paris-Saint-Antoine, France.

Cellular processes underlying ontogenesis and regression of streptozotocin (STZ)-induced diabetes in newborn rats were investigated at the most severe stage of diabetes at day 3 and after recovery of normoglycemia at day 8 by immunocytochemistry and quantitative analysis. A previously unknown endocrine cell type subpopulation (PEPS) was identified. It was characterized by granule polymorphism, coexpression of insulin and glucagon immunoreactivity, and a proliferative capacity transiently higher than in B cells. In STZ-treated rats at day 3, B cell mass decreased 14-fold, whereas PEPS cells were unaffected. The islet mass was restored to 55.7% by day 8, with a concomitant appearance of numerous small islets contiguous to small ducts. B cell mass increased by 6.9-fold compared with 1.8-fold in control rats, although proliferative capacities remained similar. Proliferation dropped considerably by day 8, preventing complete B cell mass recovery in STZ-treated rats. STZ-induced neonatal diabetes thus stimulates neogenesis of islets close to ducts and proliferation of PEPS cells. Those partially differentiated islet cells appear to be on the differentiation pathway of stem cells to fully differentiated B cells.


This article has been cited by other articles:


Home page
 FASEB J.Home page
A. GAROFANO, P. CZERNICHOW, and B. BRÉANT
Impaired {beta}-cell regeneration in perinatally malnourished rats: a study with STZ
FASEB J, December 1, 2000; 14(15): 2611 - 2617.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Cell Physiol.Home page
E. Bertelli and M. Bendayan
Intermediate endocrine-acinar pancreatic cells in duct ligation conditions
Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1641 - C1649.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online